Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Implementation Science Communications|October 1, 2022
Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science frameworkAndrea L Smith, Caroline G Watts, Michael Henderson, et al.Annals of Surgical Oncology|November 13, 2015
The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control StudyAlastair D MacKenzie Ross, Lauren E Haydu, Michael J Quinn, et al.Annals of Surgery|February 28, 2009
Proposed quality standards for regional lymph node dissections in patients with melanomaAndrew J Spillane, Bernard L H Cheung, Jonathan R Stretch, et al.Journal of Surgical Oncology|March 27, 2023
Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissectionLodewijka H J Holtkamp, Serigne N Lo, John F Thompson, et al.Annals of Surgical Oncology|July 19, 2012
Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based surveySandro Pasquali, Andrew J Spillane, Johannes H W de Wilt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2017
Conditional Survival: An Assessment of the Prognosis of Patients at Time Points After Initial Diagnosis and Treatment of Locoregional Melanoma MetastasisLauren E Haydu, Richard A Scolyer, Serigne Lo, et al.Annals of Surgery|February 22, 2013
The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomasSandro Pasquali, Lauren E Haydu, Richard A Scolyer, et al.Annals of Surgical Oncology|May 8, 2014
Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal diseaseAugustinus P T van der Ploeg, Lauren E Haydu, Andrew J Spillane, et al.Annals of Surgical Oncology|May 10, 2015
Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single CenterLauren E Haydu, Joram T Stollman, Richard A Scolyer, et al.Annals of Surgical Oncology|May 31, 2012
Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patientsAndrew J Spillane, Lauren E Haydu, Nicholas C Lee, et al.Pageof 11